RAPH

RAPHAEL PHARMACEUTICL INC by RAPHAEL PHARMACEUTICAL INC. (RAPH)

About RAPHAEL PHARMACEUTICL INC by RAPHAEL PHARMACEUTICAL INC. (RAPH)

Raphael Pharmaceutical, Inc. is a clinical-stage biotechnology company. It is focused on providing a novel cannabinoid-based research platform for the treatment of inflammatory diseases. The firm’s product candidate, HPC1, is a cannabinoid formulation developed for the treatment of rheumatoid arthritis. The company was founded in May 2007 and is headquartered in Tel Aviv, Israel.

Details

Daily high
$1.40
Daily low
$1.40
Price at open
$1.40
52 Week High
$1.40
52 Week Low
$0.04
Market cap
28.2M
Dividend yield
0.00%
Volume
100
Avg. volume
18
P/E ratio
-21.54

RAPHAEL PHARMACEUTICL INC by RAPHAEL PHARMACEUTICAL INC. News

Details

Daily high
$1.40
Daily low
$1.40
Price at open
$1.40
52 Week High
$1.40
52 Week Low
$0.04
Market cap
28.2M
Dividend yield
0.00%
Volume
100
Avg. volume
18
P/E ratio
-21.54